MTHFR and autoimmune polyendocrinopathy: Although there was no significant difference in the MTHFR C677T genotype distribution between the APS patients and the aPL(+) carriers, the performance of the MTHFR 677T polymorphism in the current study provides researchers with guidelines for the future.